Efficacy Study of Phytotherapy "Raylis" In Congestive Processes Of The Pelvic Organs (Prostatostasis)

Inclusion Criteria: * Age 20-60 years * Symptoms of prostatostasis lasting for at least 3 months during the past 6 months: * Pathological changes on uroflowmetry (maximum flow rate of less than 15 ml / s, average urinary flow rate of less than 12 ml / sec) * TRUS Prostate volume more than 22 ml at TRUS * TRUS picture of Prostatostasis * I-PSS 7-20 * IIEF-5) - 12-21 Exclusion Criteria: * Contraindications and limitations to use of the drug Raylis listed in the instructions for medical use \* * Diabetes mellitus (type 1 and type 2, decompensation) * Neurogenic disorders (acute cerebral circulatory disorders, Alzheimer's disease, spinal cord injury) * A history of pelvic trauma * Patients who had undergone radical prostatectomy and other surgical interventions on the pelvic organs * Concomitant use of supplements to improve the erectile function, use of the anti-androgens, anti-depressants, finasteride. * Diagnosed BPH * Current participation in a clinical trial and / or study medication for 30 days prior to inclusion * Any form of substance abuse, mental disorder or condition which, in the opinion of the investigator, may complicate communication with the researcher. * The inability or unwillingness to comply with the scheme of visits according to protocol.